Breaking News Instant updates and real-time market news.

DRI

Darden

$61.89

0.53 (0.86%)

, KBR

KBR

$14.31

0.68 (4.99%)

12:29
10/04/16
10/04
12:29
10/04/16
12:29

On The Fly: Top stock stories at midday

Stocks began the session in positive territory and drifted for the opening hour without any conviction. Eventually the averages crossed into negative territory and they have since moved in a narrow range, crossing back and forth across the flat line as they search for direction. Oil prices are higher and nearing $49 per barrel while gold has moved in the opposite direction, falling below $1,300 an ounce for the first time since late June. ECONOMIC NEWS: In the U.S., no major economic data was reported. In Europe, U.K. construction PMI improved to a reading of 52.3 for September, above consensus of 49. Eurozone producer prices fell 0.2% in August, below expectations for unchanged prices for the month. Additionally, the International Monetary Fund, in its regular World Economic Outlook, trimmed its forecast for U.S. growth this year by 0.6% and next year by 0.3%. For the global economy, the IMF made no changes to its forecast of 3.1% growth this year and 3.4% growth in 2017. COMPANY NEWS: Shares of Darden Restaurants (DRI) rose 1% after the company posted reported better than expected quarterly earnings, helped by climbing same-store sales at its Olive Garden chain, and raised its full-year profit forecast. MAJOR MOVERS: Among the notable gainers was KBR (KBR), which rebounded 5% to recapture part of yesterday's losses. This morning, Deutsche Bank analyst Chad Dillard upgraded the stock to Buy as he believes the post-guidance cut sell-off was overdone and backward-looking. Also higher was Sears (SHLD), which gained about 13% after Bloomberg said the company may be considering a sale of its Craftsman tool business, which has attracted several bidders including Stanley Black & Decker (SWK) and Hong Kong's Techtronic Industries. Among the noteworthy losers was Dr Pepper Snapple Group (DPS), which slipped about 4% following a media report saying that Bai Brands is exploring a potential sale. Evercore ISI analyst Robert Ottenstein downgraded Dr Pepper shares to Neutral as he believes the loss of Bai, one of its key allied brands, may shift investor's psychology on the stock. Also lower was Trinity Biotech (TRIB), which plunged 50% after the company announced that it is withdrawing its 510(k) premarket notification submission for the Meritas Troponin-I Test and Meritas Point-of-Care Analyzer after a meeting the FDA revealed "some concerns" regulators have about the submission. INDEXES: Near midday, the Dow was down 30.41, or 0.17%, to 18,223.44, the Nasdaq was up 2.98, or 0.06%, to 5,303.85, and the S&P 500 was down 3.41, or 0.16%, to 2,157.79.

DRI

Darden

$61.89

0.53 (0.86%)

KBR

KBR

$14.31

0.68 (4.99%)

SHLD

Sears

$11.37

-0.09 (-0.79%)

SWK

Stanley Black & Decker

$123.29

0.53 (0.43%)

DPS

Dr Pepper Snapple

$87.12

-3.64 (-4.01%)

TRIB

Trinity Biotech

$12.99

-0.23 (-1.74%)

  • 04

    Oct

  • 27

    Oct

  • 02

    Nov

  • 17

    Nov

DRI Darden
$61.89

0.53 (0.86%)

08/22/16
ADAM
08/22/16
INITIATION
Target $74
ADAM
Buy
Darden initiated with a Buy at Canaccord
Canaccord analyst Lynne Collier initiated coverage on the Restaurant industry with an overall cautious outlook, saying that being selective is key. The analyst started coverage of Darden with a Buy rating and $74 price target, making it one of only four Buy rated stocks among fifteen that were initiated.
07/26/16
STFL
07/26/16
DOWNGRADE
STFL
Sell
Darden downgraded to Sell from Hold at Stifel
Stifel analyst Paul Westra downgraded Darden based on the firm's belief that the U.S. economy will probably enter a recession within nine months. As a result, the firm now expects two year industrywide comps to come in at 0.5% in the first half of 2018, versus the consensus outlook of 1.75%, Westra stated. The analyst says that Darden's Olve Garden and Longhorn brands are already seeing weak demand, while the company lacks "brand agility" amid "fierce competition." Target $53.
07/13/16
WELS
07/13/16
DOWNGRADE
WELS
Market Perform
Darden downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jeff Farmer downgraded Darden Restaurants to Market Perform citing accelerating casual dining segment same-same-store declines in June. The analyst expects a diminished rate of upward earnings revision in coming quarters. He cut his price target range for the shares to $66-$70 from $70-$74.
09/06/16
OPCO
09/06/16
NO CHANGE
Target $70
OPCO
Outperform
Darden at a 'misplaced discount' to peers, says Oppenheimer
Oppenheimer analyst Brian Bittner believes the market has presented another Darden buying opportunity, with stock valuation sitting at a "misplaced discount" to peers. Further, the analyst believes better in-store execution, improved off-premise business and elevated brand momentum can sustain sales trends above peers. Bittner also sees limited risk to upcoming Q1 results. He reiterates an Outperform rating and $70 price target on the shares.
KBR KBR
$14.31

0.68 (4.99%)

10/04/16
10/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CBS (CBS) upgraded to Buy from Sell at UBS with analyst Doug Mitchelson saying he sees any deal with Viacom (VIA) as priced into CBS shares already. He also has increased confidence in consensus estimates for CBS and sees further upside if the national TV ad market and CBS' ratings remain strong. 2. Pandora (P) upgraded to Conviction Buy from Buy at Goldman with analyst Heath Terry saying he sees significant upside to out-year estimates from premium radio and on-demand subscriptions. He expects competition to ease as new entrants slow and existing providers focus on profitability and limit "free" models. 3. Las Vegas Sands (LVS) upgraded to Buy from Neutral at BofA/Merrill with analyst Shaun Kelley saying shares remain fairly under-owned and thinks estimate revisions will move higher due to market momentum, better ROI for Parisian, Cotai infrastructure additions, and optionality from Japan and real estate. 4. KBR (KBR) upgraded to Buy from Hold at Deutsche Bank with analyst Chad Dillard saying yesterday's 10% post-guidance cut selloff is overdone and backward-looking. 5. West Marine (WMAR) upgraded to Buy from Neutral at B. Riley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/16
DBAB
10/04/16
UPGRADE
Target $16
DBAB
Buy
KBR upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Chad Dillard upgraded KBR to Buy saying yesterday's 10% post-guidance cut selloff is overdone and backward-looking. The market is under-appreciating the company's transformation to a lower-risk government/technical services firm, Dillard tells investors in a research note. He upped his price target for KBR shares to $16 from $14.
09/27/16
DBAB
09/27/16
NO CHANGE
Target $14
DBAB
Hold
Deutsche sees 'realistic path' to KBR becoming $20-$25 stock
Deutsche Bank analyst Chad Dillard says he sees a "realistic path" towards KBR becoming a $20-$25 stock as the market beings to appreciate the company's transformation to a government/technical services company. The analyst, however, keeps a Hold rating on KBR with a $14 price target. The engineering and construction company closed yesterday up 10c to $14.50. Consensus estimates for 2017-2018 are too high and a reset in expectations could cause near-term price volatility, Dillard tells investors in a research note. He is "warming" to KBR's transformation but expects a more attractive entry point "down the road."
06/29/16
KEYB
06/29/16
NO CHANGE
KEYB
KBR weakness significantly overdone, says KeyBanc
KeyBanc believes that KBR could benefit from Brexit as the U.k. may look to increase security spending in the wake of its departure from the EU, according to the firm. The firm thinks that investors are undervaluing the company's Magnolia LNG project. It keeps a $24 price target and Overweight rating on the shares.
SHLD Sears
$11.37

-0.09 (-0.79%)

03/17/16
EVER
03/17/16
NO CHANGE
EVER
Sears could trade as low as $3 per share, says Evercore ISI
02/09/16
EVER
02/09/16
NO CHANGE
EVER
Sell
Sears liquidity event a matter of 'when, not if,' says Evercore ISI
Evercore ISI analyst Greg Melich said the preliminary Q4 financials released by Sears showed comparable sales were worse than he expected at the flagship brand and at Kmart and that its margins were also worse than he thought. Sear's cash situation has gotten worse, making additional debt issuance more likely in 2016, Melich tells investors, adding that he believes "a liquidity event is a matter of when not if," and may be possible in 2017 at the current burn rate. The analyst keeps a Sell rating on Sears shares.
02/09/16
EVER
02/09/16
NO CHANGE
EVER
Sears is not a viable retailer, says Evercore ISI
Evercore ISI does not believe Sears is a viable retailer in its current form, and a liquidity event is a matter of when, not if. The firm's analyst said Sears' cash situation has deteriorated, making additional debt issuance more likely in 2016 with a larger liquidity event possible in 2017. Evercore has a base case of $4 per share on Sears based on its SOTP analysis.
SWK Stanley Black & Decker
$123.29

0.53 (0.43%)

07/19/16
CLVD
07/19/16
NO CHANGE
CLVD
Stanley Black & Decker Q2 tool deman appears softer, says Cleveland Research
07/25/16
ZELM
07/25/16
DOWNGRADE
ZELM
Hold
Stanley Black & Decker downgraded to Hold from Buy at Zelman
08/22/16
LBOW
08/22/16
DOWNGRADE
LBOW
Neutral
Stanley Black & Decker downgraded to Neutral from Buy at Longbow
Longbow analyst David MacGregor downgraded Stanley Black & Decker to Neutral siting balanced risk/reward as shares are up 35% since mid-Q1 2016.
08/22/16
08/22/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Workday (WDAY) downgraded to Mixed from Positive at OTR Global and to Hold from Buy at Needham with Needham analyst Scott Berg citing industry checks that indicate second quarter billings upside will be limited and Financials sales remain challenging. 2. Garmin (GRMN) downgraded to Market Perform from Outperform at Raymond James with analyst Tavis McCourt citing valuation. 3. Urban Outfitters (URBN) downgraded to Neutral from Buy at Goldman with analyst Lindsay Drucker Mann saying Urban has successfully turned around the UO brand and is near-peak operating performance, leaving less room for meaningful improvement from here. 4. Stanley Black & Decker (SWK) downgraded to Neutral from Buy at Longbow with analyst David MacGregor citing balanced risk/reward as shares are up 35% since mid-first quarter. 5. Madison Square Garden (MSG) downgraded to Hold from Buy at Jefferies with the firm citing valuation and lack of near-term catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DPS Dr Pepper Snapple
$87.12

-3.64 (-4.01%)

10/04/16
BERN
10/04/16
NO CHANGE
Target $92
BERN
Market Perform
Dr Pepper Snapple top line at risk if Bai business lost, says Bernstein
After Reuters reported that Bai, the seller of antioxidant infusion drinks that is allied with Dr Pepper Snapple and in which the beverage company has a minority equity investment, is exploring a potential sale, Bernstein analyst Ali Dibadj said the firm's analysis suggests that the loss of Bai from Dr Pepper's system could result in a meaningful 100 basis point drag on the company's top line. Allied brands distributed by Dr. Pepper, like Bai, have been driving at least half of its topline growth recently, added Dibadj, who keeps a Market Perform rating on the stock.
10/04/16
EVER
10/04/16
DOWNGRADE
EVER
Hold
Dr Pepper Snapple downgraded to Hold from Buy at Evercore ISI
10/04/16
10/04/16
DOWNGRADE

Hold
Dr Pepper Snapple downgraded on Bai Brands potential sale at Evercore ISI
As previously reported, Evercore ISI downgraded Dr Pepper Snapple to Hold form Buy. Analyst Robert Ottenstein said reports that Bai Brands is looking for a new owner are credible and could change investor's psychology on the stock and its Allied Brands business. The analyst believes Bai Brands will get sold and result in loss of distribution, negatively impacting earnings by 20c-25c. Further, Ottenstein said consumers are increasingly concerned about sugar and it is on the radar screen of local governments as a revenue source.
10/04/16
10/04/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at Raymond James with analyst David Long saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook. 2. Kinder Morgan (KMI) downgraded to Hold from Buy at Stifel analyst Selman Akyol citing valuation. 3. GrubHub (GRUB) downgraded to Hold from Buy at Stifel with analyst John Egbert citing valuation. 4. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Evercore ISI with analyst Robert Ottenstein saying reports that Bai Brands is looking for a new owner are credible and could change investor's psychology on the stock and its Allied Brands business. 5. Dollar Tree (DLTR) downgraded to Neutral from Buy at Cleveland Research with the firm saying sales trends appear to have slowed further at Family Dollar as the company struggles with increased price competition, difficult comps, and strategy headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TRIB Trinity Biotech
$12.99

-0.23 (-1.74%)

10/23/15
CHLM
10/23/15
DOWNGRADE
Target $14
CHLM
Hold
Trinity Biotech downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum downgraded Trinity Biotech to Hold to reflect continued slow growth and weak margins in the existing business. The firm lowered its price target on shares to $14 from $24.
10/23/15
10/23/15
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: A. Schulman (SHLM) downgraded to Accumulate from Buy at Seaport Global... American Electric (AEP) downgraded to Neutral from Outperform at Credit Suisse... Applied Materials (AMAT) downgraded to Neutral from Buy at Citi... ArcelorMittal (MT) downgraded to Neutral from Outperform at Credit Suisse... BE Aerospace (BEAV) downgraded to Sector Perform from Outperform at RBC Capital... Banner Corp. (BANR) downgraded to Market Perform from Outperform at Keefe Bruyette... CEMEX (CX) downgraded to Equal Weight from Overweight at Barclays... Cabela's (CAB) downgraded to Market Perform from Outperform at Barrington... Cameron (CAM) downgraded to Market Perform from Outperform at Raymond James... Community Financial (TCFC) downgraded to Market Perform at Keefe Bruyette... Cypress Semiconductor (CY) downgraded to Buy from Strong Buy at Needham... Diana Shipping (DSX) downgraded to Hold from Buy at Jefferies... Dunkin' Brands (DNKN) downgraded to Neutral from Overweight at Piper Jaffray... Emerge Energy (EMES) downgraded to Neutral from Buy at Seaport Global... Enanta (ENTA) downgraded to Underweight from Equal Weight at Barclays... FireEye (FEYE) downgraded to Neutral from Outperform at Wedbush... Freescale (FSL) downgraded ahead of deal closing at Bernstein... GNC Holdings (GNC) downgraded to Neutral from Buy at Sterne Agee CRT... Heritage Financial (HFWA) downgraded to Market Perform at Keefe Bruyette... Huron (HURN) downgraded to Underperform from Outperform at Avondale... Independent Bank (IBTX) downgraded to Hold from Buy at Sandler O'Neill... KLX Inc. (KLXI) downgraded at RBC Capital... LaSalle Hotel (LHO) downgraded to Neutral from Outperform at Credit Suisse... LifePoint (LPNT) downgraded to Buy from Conviction Buy at Goldman... Mead Johnson (MJN) downgraded to Neutral from Outperform at Credit Suisse... Mindray Medical (MR) downgraded to Hold from Buy at Deutsche Bank... NASDAQ (NDAQ) downgraded to Market Perform from Outperform at Wells Fargo... Ocular Therapeutix (OCUL) downgraded to Equal Weight from Overweight at Morgan Stanley... Pandora (P) downgraded to Neutral from Buy at BofA/Merrill... Pebblebrook Hotel (PEB) downgraded to Neutral from Outperform at Credit Suisse... Plexus (PLXS) downgraded to Neutral from Buy at Goldman... Quidel (QDEL) downgraded to Hold from Buy at Craig-Hallum... Quotient Technology (QUOT) downgraded to Hold from Buy at Craig-Hallum... Raytheon (RTN) downgraded to Peer Perform from Outperform at Wolfe Research... Safe Bulkers (SB) downgraded to Hold from Buy at Jefferies... Sanmina (SANM) downgraded to Sell from Neutral at Citi... Skechers (SKX) downgraded to Neutral from Buy at Buckingham... Stericycle (SRCL) downgraded to Neutral from Outperform at Baird... Teck Resources (TCK) downgraded to Sell from Hold at Deutsche Bank... Trinity Biotech (TRIB) downgraded to Hold from Buy at Craig-Hallum... USG (USG) downgraded to Hold from Buy at Jefferies... Ultra Clean (UCTT) downgraded to Hold from Buy at Craig-Hallum... Under Armour (UA) downgraded to Hold from Buy at BB&T... Union Pacific (UNP) downgraded to Underperform at Avondale... Vishay (VSH) downgraded to Sell from Neutral at Citi... WABCO (WBC) downgraded to Buy from Conviction Buy at Goldman.
03/04/16
SPHN
03/04/16
NO CHANGE
Target $22
SPHN
Overweight
Trinity Biotech remains top Diagnostics/Life Science Tools idea at Stephens
Stephens analyst Drew Jones said Trinity Biotech remains his favorite idea in the Diagnostics/Life Science Tools space for 2016 in a post-earnings research note. The company second straight quarter of matching consensus earnings expectations has re-established "some much needed credibility" on its execution, according to Jones, looks for an acceleration in organic growth this year. The analyst keeps an Overweight rating and $22 price target on Trinity shares.
04/21/16
ROTH
04/21/16
NO CHANGE
Target $13
ROTH
Buy
Roth Capital remains bullish on long-term Trinity Biotech troponin opportunity
Roth Capital analyst Chris Lewis remains bullish on the long-term Trinity Biotech's troponin opportunity, after the company received the FDA's formal response for its troponin 510k submission, which does not request any extensive additional data. However, the analyst looks for improved underlying growth and profitability trends to materialize to gain higher near-term conviction on the name. Lewis reiterates a Buy rating and $13 price target on the shares.

TODAY'S FREE FLY STORIES

X

U.S. Steel

$37.49

1.54 (4.28%)

18:49
12/07/16
12/07
18:49
12/07/16
18:49
Periodicals
U.S. Steel CEO: Company may bring back 10,000 U.S. jobs, CNBC says »

U.S. Steel could bring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda

$15.40

-0.6 (-3.75%)

18:47
12/07/16
12/07
18:47
12/07/16
18:47
Hot Stocks
Vanda settles Fanapt patent litigation with Apotex »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AE

Adams Resources

$42.31

-0.68 (-1.58%)

, SWN

Southwestern Energy

$12.37

-0.08 (-0.64%)

18:46
12/07/16
12/07
18:46
12/07/16
18:46
Hot Stocks
Adams Resources appoints Josh Anders as CFO »

Adams Resources &…

AE

Adams Resources

$42.31

-0.68 (-1.58%)

SWN

Southwestern Energy

$12.37

-0.08 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EZPW

EZCORP

$11.80

0.05 (0.43%)

18:42
12/07/16
12/07
18:42
12/07/16
18:42
Earnings
EZCORP reports Q4 EPS with items (31c), may not compare to consensus 6c »

EPS figure includes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

RICE

Rice Energy

$24.59

-0.16 (-0.65%)

18:33
12/07/16
12/07
18:33
12/07/16
18:33
Initiation
Rice Energy initiated  »

Rice Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$770.42

5.7 (0.75%)

18:30
12/07/16
12/07
18:30
12/07/16
18:30
Periodicals
Amazon spokesperson denies 2,000 grocery stores report, CNET says »

Following a report by the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICON

Iconix Brand

$9.26

0.14 (1.54%)

18:23
12/07/16
12/07
18:23
12/07/16
18:23
Hot Stocks
Iconix Brand reports employment termination of Chief Strategy Officer Blumberg »

Iconix Brand disclosed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBYI

Puma Biotechnology

$39.80

-2 (-4.78%)

18:23
12/07/16
12/07
18:23
12/07/16
18:23
Hot Stocks
Puma Biotechnology 'pleased' to complete biomarker analysis of neratinib »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTK

Flotek

$11.10

-2.01 (-15.33%)

18:17
12/07/16
12/07
18:17
12/07/16
18:17
Hot Stocks
Flotek: Reviewing FourWorld Capital short report, remain confident in product »

Speaking earlier during…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

PBYI

Puma Biotechnology

$39.80

-2 (-4.78%)

18:09
12/07/16
12/07
18:09
12/07/16
18:09
Hot Stocks
Puma Biotechnology 'pleased' with preliminary neratinib activity »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNM

PNM Resources

$32.05

0.45 (1.42%)

18:09
12/07/16
12/07
18:09
12/07/16
18:09
Hot Stocks
PNM Resources requests an electric rate increase of $99M in New Mexico »

PNM Resources' New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BK

BNY Mellon

$48.55

0.56 (1.17%)

18:03
12/07/16
12/07
18:03
12/07/16
18:03
Periodicals
BNY Mellon outage led to certain Swift payment failures, WSJ reports »

Bank of New York Mellon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

17:52
12/07/16
12/07
17:52
12/07/16
17:52
Hot Stocks
Tailored Brands up 22% to $23.20 after Q3 results beat estimates »

The company also raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

FLXS

Flexsteel Industries

$59.12

2.92 (5.20%)

, UNH

UnitedHealth

$159.40

2.08 (1.32%)

17:50
12/07/16
12/07
17:50
12/07/16
17:50
Hot Stocks
Flexsteel names Eric Rangen chair of the board »

Flexsteel Industries…

FLXS

Flexsteel Industries

$59.12

2.92 (5.20%)

UNH

UnitedHealth

$159.40

2.08 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$52.10

1.53 (3.03%)

, UA

Under Armour

$27.03

1.62 (6.38%)

17:49
12/07/16
12/07
17:49
12/07/16
17:49
Periodicals
Nike losing market share to faster-growing rivals, Barron's reports »

Despite being down nearly…

NKE

Nike

$52.10

1.53 (3.03%)

UA

Under Armour

$27.03

1.62 (6.38%)

ADDYY

adidas

$76.96

1.225 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

T

AT&T

$40.45

1.1 (2.80%)

17:45
12/07/16
12/07
17:45
12/07/16
17:45
Conference/Events
AT&T management to meet with Jefferies »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

EFC

Ellington Financial

$16.30

0.2 (1.24%)

17:41
12/07/16
12/07
17:41
12/07/16
17:41
Hot Stocks
Ellington Financial reports estimated book value per share $19.80 as of Nov 30 »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

lululemon

$59.84

2.6 (4.54%)

, HRB

H&R Block

$23.34

0.65 (2.86%)

17:39
12/07/16
12/07
17:39
12/07/16
17:39
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

LULU

lululemon

$59.84

2.6 (4.54%)

HRB

H&R Block

$23.34

0.65 (2.86%)

VYGR

Voyager Therapeutics

$13.73

-0.27 (-1.93%)

GLW

Corning

$24.58

0.59 (2.46%)

CMTL

Comtech

$12.75

0.77 (6.43%)

VRNT

Verint

$38.30

0.1 (0.26%)

UNFI

United Natural Foods

$49.09

0.43 (0.88%)

OLLI

Ollie's Bargain Outlet

$31.85

0.35 (1.11%)

MIND

Mitcham Industries

$3.73

0.04 (1.08%)

CASY

Casey's General Stores

$124.22

1.14 (0.93%)

OHRP

Ohr Pharmaceutical

$2.53

-0.075 (-2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 15

    Dec

  • 09

    Jan

  • 09

    Jan

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

17:38
12/07/16
12/07
17:38
12/07/16
17:38
Hot Stocks
Tailored Brands says making 'solid progress' on cost reduction initiatives »

"Our improved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

17:37
12/07/16
12/07
17:37
12/07/16
17:37
Hot Stocks
Tailored Brands says on track to achieve targeted $50M of cost savings in FY16 »

"We are on track to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

17:36
12/07/16
12/07
17:36
12/07/16
17:36
Hot Stocks
Tailored Brands reports Q3 Men's Wearhouse SSS up 0.1% »

Reports Q3: Jos. A. Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

VLKAY

Volkswagen

$28.94

0.895 (3.19%)

17:35
12/07/16
12/07
17:35
12/07/16
17:35
Periodicals
EU to take action against seven countries over emissions failings, Reuters says »

After the Volkswagen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

17:33
12/07/16
12/07
17:33
12/07/16
17:33
Earnings
Tailored Brands revises FY16 adjusted EPS view to $1.70-$1.85 from $1.55-$1.85 »

FY16 consensus $1.70.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

17:31
12/07/16
12/07
17:31
12/07/16
17:31
Earnings
Tailored Brands reports Q3 adjusted EPS 68c, consensus 55c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DAL

Delta Air Lines

$51.10

1.67 (3.38%)

17:23
12/07/16
12/07
17:23
12/07/16
17:23
Periodicals
Delta experiments with free meals in coach, Bloomberg says »

Delta is testing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.